Skip to content

Ischemic Preconditioning as an Intervention to Improve Stroke Rehabilitation - Froedtert

Ischemic Preconditioning as an Intervention to Improve Stroke Rehabilitation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03023150
Enrollment
20
Registered
2017-01-18
Start date
2016-10-31
Completion date
2023-08-31
Last updated
2023-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Preconditioning, Physical and Rehabilitation Medicine, Stroke Rehabilitation

Brief summary

This study will be the first study to use ischemic preconditioning (IPC) as an intervention to improve stroke rehabilitation. IPC is a well studied, well tolerated intervention which has been shown to improve regional blood flow, motor neuron excitability and muscle function in multiple patient groups and in young, healthy subjects. Because IPC targets three physiological systems which are all affected by stroke, we hypothesize that repeated bouts of IPC during the first days to months following stroke (when the majority of recovery occurs) will make traditional rehabilitation strategies more effective.

Interventions

OTHERIschemic Preconditioning
OTHERSham

Sponsors

Marquette University
CollaboratorOTHER
Medical College of Wisconsin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. be between the ages of 40-80 2. able to give informed consent. 3. be \< 6 months post diagnosis of unilateral cortical stroke and 4. have residual leg paresis.

Exclusion criteria

1. chronic low back or hip pain 2. substance abuse 3. head trauma with loss of conciousness in last 6 months 4. neurodegenerative disorder 5. participant taking any medication or supplement that adversely interacts with nitroglycerin (exclusion from nitro administration only, applies to outpatients only) 6. participant has a known allergy to nitroglycerin (exclusion from nitro administration only, applies to outpatients only) 7. resting systolic blood pressure \< 90mmHg (exclusion from nitro administration only, applies to outpatients only) 8. any condition where knee extension contractions are contraindicated 9. people who are unable to follow multi step commands. 10. pregnancy (DXA scan exclusion only) 11. history of major psychiatric disorder 12. participant has had a myocardial infarction in the last year 13. participant has stage II hypertension (BP\>160/100) 14. participant is unable to contract knee muscles 15. participant is unable to sit upright for 2 hours 16. participant has a resting heart rate \>100 beats per minute 17. history of multiple strokes

Design outcomes

Primary

MeasureTime frame
Change in Knee Extensor StrengthAdmission into study and within 3 days of Discharge from Froedtert Hospital

Secondary

MeasureTime frame
Change in Walking SpeedAdmission into study and within 3 days of Discharge from Froedtert Hospital

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026